← Back to Clinical Trials
Recruiting NCT05127265

NCT05127265 Pervasive Sensing and AI in Intelligent ICU

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05127265
Status Recruiting
Phase
Sponsor University of Florida
Condition Critical Illness
Study Type OBSERVATIONAL
Enrollment 400 participants
Start Date 2021-05-24
Primary Completion 2026-12

Trial Parameters

Condition Critical Illness
Sponsor University of Florida
Study Type OBSERVATIONAL
Phase N/A
Enrollment 400
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-05-24
Completion 2026-12
Interventions
Video MonitoringAccelerometer MonitoringNoise Level Monitoring

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Important information related to the visual assessment of patients, such as facial expressions, head and extremity movements, posture, and mobility are captured sporadically by overburdened nurses, or are not captured at all. Consequently, these important visual cues, although associated with critical indices such as physical functioning, pain, delirious state, and impending clinical deterioration, often cannot be incorporated into clinical status. The overall objectives of this project are to sense, quantify, and communicate patients' clinical conditions in an autonomous and precise manner, and develop a pervasive intelligent sensing system that combines deep learning algorithms with continuous data from inertial, color, and depth image sensors for autonomous visual assessment of critically ill patients. The central hypothesis is that deep learning models will be superior to existing acuity clinical scores by predicting acuity in a dynamic, precise, and interpretable manner, using autonomous assessment of pain, emotional distress, and physical function, together with clinical and physiologic data.

Eligibility Criteria

Inclusion Criteria: * aged 18 or older * admitted to UF Health Shands Gainesville ICU ward * expected to remain in ICU ward for at least 24 hours at time of screening Exclusion Criteria: * under the age of 18 * on any contact/isolation precautions * expected to transfer or discharge from the ICU in 24 hours or less * unable to provide self-consent or has no available proxy/LAR

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology